Litigation Details for Javid Siminou v. Teva Pharmaceuticals USA Inc (C.D. Cal. 2014)
✉ Email this page to a colleague
Javid Siminou v. Teva Pharmaceuticals USA Inc (C.D. Cal. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-03-26 |
| Court | District Court, C.D. California | Date Terminated | 2014-07-31 |
| Cause | 15:0001 Antitrust Litigation | Assigned To | Robert G. Klausner |
| Jury Demand | Plaintiff | Referred To | Andrew J Wistrich |
| Parties | DURAMED PHARMACEUTICALS INC | ||
| Patents | 6,015,577 | ||
| Attorneys | Patrick Charles Cooper | ||
| Firms | Ward & Wilson LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Javid Siminou v. Teva Pharmaceuticals USA Inc
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Javid Siminou v. Teva Pharmaceuticals USA Inc (C.D. Cal. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-03-26 | 1 | After Boehringer submitted Patent 7 No. 6,015,577 (the “‘577 Patent”) to the FDA for listing in … 1 patent; (2) that a patent on the brand-name drug has expired; (3) that a brand-name patent exists…filed a patent infringement lawsuit against Barr. 26 3. To dispose of the patent litigation…compared to typical patent litigation where a potential infringer pays the patent holder 19 to resolve…name manufacturer’s patent without infringing the brand-name manufacturer’s patent. This allows 19 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
